511 Patients with T3 N0-3 M0 squamous cell carcinoma of the larynx, treated in the Netherlands from 1975 until 1984, were retrospectively analysed. Four different treatment policies were followed: primary surgery, planned combination of radiotherapy and surgery, primary radical radiotherapy, and selective radiotherapy. General results are presented. Local control rate was 72%. Regional control rate was 90% for clinically N0 patients and 78% for clinically N+ patients. Salvage therapy was overall successful in 38%. Surgical salvage for local radiation failures (with regional relapse) was successful in 69%, and for regional failures (without local relapse) in 46%. Ultimate locoregional control was 78% and, due to 8% distant metastases, 5-year...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...
In a nationwide survey on oropharyngeal carcinoma in the Netherlands (1986-1990), 380 patients with ...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...
The Dutch Co-operative Head and Neck Oncology Group performed a retrospective, nationwide study of l...
BACKGROUND: Treatment strategies for T3 laryngeal carcinoma include radiotherapy (RT) with or withou...
Background: Treatment strategies for T3 laryngeal carcinoma include radiotherapy (RT) with or withou...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
Objectives This study compared the survival outcomes, local control rate, and laryngeal preservation...
The purpose of this study was to determine time trends for primary treatment modalities in advanced ...
Six hundred sixty-eight patients with tumours of the larynx were treated by radiotherapy. The patien...
Objective Survival of patients with advanced laryngeal squamous cell carcinoma (LSCC) remains poor a...
PURPOSE: This evidence based guideline aims to facilitate proper management and to prevent diverging...
10%–15 % of all head and neck cancers. At presenta-tion 60%–70 % will have advanced-stage disease wi...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...
In a nationwide survey on oropharyngeal carcinoma in the Netherlands (1986-1990), 380 patients with ...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...
The Dutch Co-operative Head and Neck Oncology Group performed a retrospective, nationwide study of l...
BACKGROUND: Treatment strategies for T3 laryngeal carcinoma include radiotherapy (RT) with or withou...
Background: Treatment strategies for T3 laryngeal carcinoma include radiotherapy (RT) with or withou...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
The optimal treatment for T3 laryngeal carcinoma (LC) is still a matter of debate. Different therape...
Objectives This study compared the survival outcomes, local control rate, and laryngeal preservation...
The purpose of this study was to determine time trends for primary treatment modalities in advanced ...
Six hundred sixty-eight patients with tumours of the larynx were treated by radiotherapy. The patien...
Objective Survival of patients with advanced laryngeal squamous cell carcinoma (LSCC) remains poor a...
PURPOSE: This evidence based guideline aims to facilitate proper management and to prevent diverging...
10%–15 % of all head and neck cancers. At presenta-tion 60%–70 % will have advanced-stage disease wi...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...
In a nationwide survey on oropharyngeal carcinoma in the Netherlands (1986-1990), 380 patients with ...
BACKGROUND: The purpose of this study was to determine time trends for primary treatment modalities ...